- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02536898
Norwegian Capture the Fracture Initiative (NoFRACT)
March 21, 2022 updated by: Lene Bergendal Solberg, Oslo University Hospital
The main aim is to assess the effectiveness of introducing a standardized intervention program for treatment of patients with a fragility fracture as measured by changes in the fracture rates and the mortality.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
A fracture liaison service model of care is widely recommended but data on its effectiveness regarding reduced risk of recurrent fracture and fracture related mortality are scarce.
The investigators therefore aim to assess the risk of subsequent fractures and mortality after a clinical fracture in patients who present to hospitals with a standardized intervention program.
Seven Norwegian hospitals will be Stepped Wedge Cluster Randomized to a standardized intervention program with startup date between May 2015 and Jan 2016.
The intervention will last throughout 2018 with follow-up throughout 2019.
Outcomes before and after the intervention will be compared and each hospital will act as its own control.
The effect of the intervention will be measured by using national patient registries on fractures and mortality.
Study Type
Interventional
Enrollment (Actual)
94260
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bergen, Norway
- Haukeland University Hospital
-
Drammen, Norway
- Drammen Hospital
-
Molde, Norway
- Molde Hospital
-
Oslo, Norway
- Oslo University Hospital
-
Sandvika, Norway
- Bærum Hospital
-
Tromsø, Norway
- University Hospital of North Norway
-
Trondheim, Norway
- St. Olavs University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Low-energy fracture
Exclusion Criteria:
- finger fracture, toe fracture, face fracture, skull fracture
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fracture liaison service
|
|
Other: Current treatment
Treatment as offered before intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fragility fracture
Time Frame: 4 years
|
Incidence of fragility fractures per 10,000 person-years (distal forearm fractures, proximal humerus fractures and hip fractures)
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: 4 years
|
Total number of deaths during four years after enrollment
|
4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Lars Nordsletten, PhD, Oslo University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Actual)
January 1, 2020
Study Completion (Actual)
May 1, 2020
Study Registration Dates
First Submitted
April 30, 2015
First Submitted That Met QC Criteria
August 31, 2015
First Posted (Estimate)
September 1, 2015
Study Record Updates
Last Update Posted (Actual)
March 22, 2022
Last Update Submitted That Met QC Criteria
March 21, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015/334
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fracture
-
University Health Network, TorontoNot yet recruitingSurgery | Hip-fracture
-
Lund UniversityMalmo Municipality, SwedenRecruiting
-
Hvidovre University HospitalCompleted
-
Michal Roll PhD,MBATel-Aviv Sourasky Medical CenterUnknown
-
The University of Hong KongRecruiting
-
Mayo ClinicCompletedPertrochanteric Hip FractureUnited States
-
Eurofarma Laboratorios S.A.TerminatedHip Fracture SurgeryBrazil
-
National Institute of Arthritis and Musculoskeletal...Completed
-
AO Clinical Investigation and Publishing DocumentationCompletedHip Fractures | Closed Fracture of HipIsrael, Austria, Switzerland, Germany, Belgium, Norway
Clinical Trials on Fracture Liaison Service
-
Groupe Hospitalier Paris Saint JosephTerminated
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruiting
-
Aydin Adnan Menderes UniversityRecruiting
-
Hebrew SeniorLifeBrown University; Duke University; National Institute on Aging (NIA)CompletedAccidental Falls/Prevention and ControlUnited States
-
University of ZurichHeidelberg UniversityActive, not recruitingConsultation-Liaison Intervention for Patients With Depression and Anxiety in Primary Care (CoLiPri)Depression | AnxietySwitzerland
-
University of British ColumbiaBritish Columbia Cancer Agency; Women's Health Research Institute of British...CompletedUterine Cervical Dysplasia | Uterine Cervix CancerCanada
-
DiaSorin Inc.Completed
-
University Hospital, GenevaCompleted
-
University of AlbertaCompleted
-
National Institute on Drug Abuse (NIDA)CompletedSee One | Do One | Order OneUnited States